Sanara MedTech Inc (SMTI)
30.47
-1.23
(-3.88%)
USD |
NASDAQ |
May 17, 16:00
30.47
0.00 (0.00%)
After-Hours: 17:35
Sanara MedTech Enterprise Value: 280.01M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 16, 2024 | 280.01M |
May 15, 2024 | 300.36M |
May 14, 2024 | 264.14M |
May 13, 2024 | 259.14M |
May 10, 2024 | 277.59M |
May 09, 2024 | 292.18M |
May 08, 2024 | 289.93M |
May 07, 2024 | 295.45M |
May 06, 2024 | 287.35M |
May 03, 2024 | 286.31M |
May 02, 2024 | 273.98M |
May 01, 2024 | 275.88M |
April 30, 2024 | 281.14M |
April 29, 2024 | 286.23M |
April 26, 2024 | 285.54M |
April 25, 2024 | 284.33M |
April 24, 2024 | 286.83M |
April 23, 2024 | 287.69M |
April 22, 2024 | 290.28M |
April 19, 2024 | 297.95M |
April 18, 2024 | 299.85M |
April 17, 2024 | 279.07M |
April 16, 2024 | 279.50M |
April 15, 2024 | 284.67M |
April 12, 2024 | 295.63M |
Date | Value |
---|---|
April 11, 2024 | 290.71M |
April 10, 2024 | 291.23M |
April 09, 2024 | 294.68M |
April 08, 2024 | 299.76M |
April 05, 2024 | 299.16M |
April 04, 2024 | 301.40M |
April 03, 2024 | 306.92M |
April 02, 2024 | 310.19M |
April 01, 2024 | 320.89M |
March 31, 2024 | 325.63M |
March 28, 2024 | 323.35M |
March 27, 2024 | 325.93M |
March 26, 2024 | 321.19M |
March 25, 2024 | 316.88M |
March 22, 2024 | 326.88M |
March 21, 2024 | 326.25M |
March 20, 2024 | 325.99M |
March 19, 2024 | 322.15M |
March 18, 2024 | 315.07M |
March 15, 2024 | 320.10M |
March 14, 2024 | 314.64M |
March 13, 2024 | 322.66M |
March 12, 2024 | 318.82M |
March 11, 2024 | 315.84M |
March 08, 2024 | 316.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
21.74M
Minimum
May 17 2019
409.13M
Maximum
Apr 10 2023
204.69M
Average
215.91M
Median
Apr 07 2021
Enterprise Value Benchmarks
AptarGroup Inc | 10.71B |
Daxor Corp | 46.42M |
Precision Optics Corp Inc | 41.44M |
Warby Parker Inc | 1.698B |
Perspective Therapeutics Inc | 890.47M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.764M |
Revenue (Quarterly) | 18.54M |
Total Expenses (Quarterly) | 20.13M |
EPS Diluted (Quarterly) | -0.21 |
Gross Profit Margin (Quarterly) | 89.80% |
Profit Margin (Quarterly) | -9.52% |
Earnings Yield | -1.94% |
Normalized Earnings Yield | -3.238 |